Antonio Palumbo
Università degli Studi di Torino
H-index: 127
Europe-Italy
Top articles of Antonio Palumbo
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
V. 01.7: A LAPAROSCOPIC AND ENDOSCOPIC COOPERATIVE SURGERY (LECS) APPROACH FOR TREATMENT OF APPENDICEAL LESION IN PATIENTS WITH SERRATED POLYPOSIS SYNDROME (SPS) | Digestive and Liver Disease | F Orbosuè S Maiero M Granziera P Pelizzo A Palumbo | 2024/4/1 |
Stem Cell Transplantation in Multiple Myeloma. CURRENT CANCER DRUG TARGETS, 17 (9), 769–781. https://doi. org/10.1174/1568009616666160910090136. | M Offidani S Gentili F Gay E Aghemo L Maracci | 2023/10/1 | |
Combination therapies using cd-38 antibodies | 2022/8/4 | ||
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre … | The Lancet Haematology | Meletios A Dimopoulos Paul G Richardson Nizar J Bahlis Sebastian Grosicki Michele Cavo | 2022/6/1 |
P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN? | HemaSphere | R Popat A Badros S Kumar P Rodriguez-Otero A Cohen | 2022/4/1 |
Molecular mechanisms associated with chemoresistance in esophageal cancer | Matheus Lohan-Codeço Maria Luísa Barambo-Wagner Luiz Eurico Nasciutti Luis Felipe Ribeiro Pinto Nathalia Meireles Da Costa | 2022/2 | |
A panel of tumor biomarkers to predict complete pathological response to neoadjuvant treatment in locally advanced rectal cancer | Oncology Research | Chiara Dalle Fratte Silvia Mezzalira Jerry Polesel Elena De Mattia Antonio Palumbo | 2022 |
Retraction notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 autoregulatory loop in multiple myeloma development | Cancer cell | Flavia Pichiorri Sung-Suk Suh Alberto Rocci Luciana De Luca Cristian Taccioli | 2022/11/14 |
Can Patient-Reported Ocular Symptoms Guide Dose Modifications in Patients with Relapsed/Refractory Multiple Myeloma Receiving Belantamab Mafodotin? | Blood | Rakesh Popat Ashraf Z Badros Shaji Kumar Paula Rodríguez-Otero Adam D Cohen | 2021/11/23 |
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies | haematologica | Roberto Mina Francesca Bonello Maria Teresa Petrucci Anna Marina Liberati Concetta Conticello | 2021/4/4 |
MM-103: Relationship Between Corneal Exam Findings, Best-Corrected Visual Acuity (BCVA), and Ocular Symptoms in Patients with Relapsed or Refractory Multiple Myeloma (RRMM … | Clinical Lymphoma Myeloma and Leukemia | Evangelos Terpos Ashraf Badros Rakesh Popat Paula Rodriguez-Otero Asim Farooq | 2021/9/1 |
métodos para tratar uma doença em um sujeito e para tratar um câncer hematológico em um sujeito, e, forma farmacêutica unitária. | 2021/1/26 | ||
Pseudopyloric metaplasia is not associated with the development of gastric cancer | Official journal of the American College of Gastroenterology| ACG | Emanuele Dilaghi Francesca Baldaro Emanuela Pilozzi Laura Conti Antonio Palumbo | 2021/9/1 |
Subcutaneous dosing of anti-cd38 antibodies | 2021/2/18 | ||
P-219: Relationship between corneal exam findings, best-corrected visual acuity, and ocular symptoms in patients with relapsed or refractory multiple myeloma receiving … | Clinical Lymphoma Myeloma and Leukemia | Evangelos Terpos Ashraf Z Badros Rakesh Popat Paula Rodríguez-Otero Asim V Farooq | 2021/10/1 |
Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network | Cancer | Francesca Gay Andreas Günther Massimo Offidani Monika Engelhardt Marco Salvini | 2021/9/15 |
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in … | Annals of hematology | Faith Davies Robert Rifkin Caitlin Costello Gareth Morgan Saad Usmani | 2021/9 |
Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life | Evangelos Terpos Joseph Mikhael Roman Hajek Ajai Chari Sonja Zweegman | 2021/2/18 | |
Polygraphic findings in simplified Barbed Reposition Pharyngoplasty (BRP) as a treatment for OSA patients | JDREAM. Journal of interDisciplinary REsearch Applied to Medicine | Caterina Arigliani Michele Arigliani Enrico Ciavolino Luana Conte Domenico Maurizio Toraldo | 2021/8/7 |
AF. 19 PSEUDOPYLORIC METAPLASIA DOES NOT GIVE RISE TO GASTRIC CANCER | Digestive and Liver Disease | E Dilaghi F Baldaro E Pilozzi L Conti A Palumbo | 2021/9/1 |
Co-Authors
